Chiesi blocks Japanese drugmaker’s new brand at EU General Court

Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing

8 March 2022 Should the MHLW and CSIMC consider competition in drug pricing, it would be necessary to formulate systems to utilise the expertise of a competition expert, namely the Japan Fair Trade Commission, says Takanori Abe of Abe & Partners.

Generics

EC plans to lower barriers to generic drugs

25 November 2020 The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.

Europe

Teva to face inhaler infringement allegations in UK court

3 June 2020 Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.

More on this story

Biotechnology

Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing

Generics

EC plans to lower barriers to generic drugs

25 November 2020 The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.

Europe

Teva to face inhaler infringement allegations in UK court

3 June 2020 Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.

More on this story

Biotechnology

Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing

Generics

EC plans to lower barriers to generic drugs

25 November 2020 The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.

Europe

Teva to face inhaler infringement allegations in UK court

3 June 2020 Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.